Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00167180
Title Post Transplant Donor Lymphocyte Infusion
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Masonic Cancer Center, University of Minnesota
Indications

hematologic cancer

Therapies

Cyclophosphamide + Fludarabine

Age Groups: child | adult
Covered Countries USA


No variant requirements are available.